Five latent factors underlie response to immunotherapy
A study by our group that identified five key factors that are significantly associated with the response of cancer patients to immunotherapy was published in Nature Genetics.
We used an unbiased approach to analyse thousands of molecular and clinical features and identified five independent factors that influence response to immunotherapy and patient survival. These findings provide a framework to interpret biomarkers of response to CPIs and suggest a future pathway to improve personalised cancer medicine.
